AI assistant
Sarepta Therapeutics, Inc. — Director's Dealing 2025
Sep 6, 2025
31721_dirs_2025-09-05_57525022-48e0-4d00-84ec-dac35c011a59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2025-09-03
Reporting Person: Estepan Ian Michael (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-03 | Common Stock | A | 93875 | — | Acquired | 156487 | Direct |
| 2025-09-03 | Common Stock | A | 50000 | — | Acquired | 206487 | Direct |
Footnotes
F1: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company.
F2: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board.